Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12 - Top-Institutions - MDSpire

Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12

  • By

  • Bente Langdahl

  • Yoon-Sok Chung

  • Rafal Plebanski

  • Edward Czerwinski

  • Eva Dokoupilova

  • Jerzy Supronik

  • Jan Rosa

  • Andrzej Mydlak

  • Anna Rowińska-Osuch

  • Ki-Hyun Baek

  • Audrone Urboniene

  • Robert Mordaka

  • Sohui Ahn

  • Young Hee Rho

  • Jisuk Ban

  • Richard Eastell

  • September 7, 2024

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Osteoporosis
    • Metabolic Bone Disease
    • Clinical Trials

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Endocrinology
    • Osteoporosis
    • Clinical Pharmacology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Bone Biology
    • Osteoporosis
    • Clinical Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Osteoporosis
    • Metabolic Bone Disease
    • Clinical Trials

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Metabolic Bone Disease
    • Osteoporosis
    • Clinical Research

Original Source(s)

Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12

  • by Bente Langdahl, Yoon-Sok Chung, Rafal Plebanski, Edward Czerwinski, Eva Dokoupilova, Jerzy Supronik, Jan Rosa, Andrzej Mydlak, Anna Rowińska-Osuch, Ki-Hyun Baek, Audrone Urboniene, Robert Mordaka, Sohui Ahn, Young Hee Rho, Jisuk Ban, Richard Eastell

  • September 7, 2024

Related Content

An explainable predictive machine learning model of osteopenia for perimenopausal women based on clinical data: a retrospective single-center study

Bone mineral density and bone turnover in adolescent girls with anorexia nervosa: a 3-year retrospective cohort study

Assessing the Predictive Utility of L1 Cortical Bone CT Parameters for Osteoporosis Risk